Bristol-Myers Squibb | DETTE



Debt Changement Date
AbbVie USD 67.14B 3.94B 2024-12
Abbott USD 13.24B 883M 2025-03
ALKERMES USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Biogen USD 6.3B 2M 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
J&J USD 52.25B 15.62B 2025-03
Medtronic USD 28.52B 1.91B 2025-04
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 118.72B 61.75B 2025-03
Perrigo USD 3.63B 9.4M 2025-03
Pfizer USD 62.11B 2.24B 2025-03
Prestige Brands USD 1.02B 18.52M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Sanofi 17.91B 5.85B 2024-12
United Therapeutics USD 200M 100M 2025-03
Zoetis USD 6.58B 7M 2025-03



Bristol-Myers Squibb DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.